Useful Links & Tools
- Bulk Quote-Order Product
- MSDS
- Certificate of Analysis
- HYSHP020 - Bulletin (85KB)
- Similar Products
HYSHP020
Sigma
Hystem™-HP Cell Culture Scaffold Kit
For 7.5 mL of hydrogel scaffold solution
Description
| Features and Benefits | Hystem-HP enables ionic binding and slow release of growth factors through thiolated heparin; growth factors can be integrated via the matrix rather than cell culture medium. Hystem-HP also enables the attachment of a wide variety of cell types through Gelin-S (thiolated gelatin). With Hystem-HP, researchers can tailor the incorporation of ECM proteins and growth factors as well as the elasticity of the hydrogel and cell incorporation (encapsulations or top plating) to create the specific 3D environment required by their cells. Hystem-HP is recommended for both in vivo and in vitro experimentation. |
| Customizable, well characterized and consistent, Hystem-HP hydrogel cell culture scaffolds provide a complex, three dimensional environment in which cells are able to proliferate, much as they would in vivo. • Customizable - each distinct cell type in a multicellular organism has its own unique microenvironment. Hystem-HP offers the flexibility to tailor the environments of cultured cells to mimic their in vivo counterparts and optimize proliferation and differentiation. • Synthetic - As a synthetic matrix, Hystem-HP offers greater control of the cellular environment than ambiguous extracted ECM alternatives. All components are well characterized and consistently formulated. Hystem-HP contains Hyaluronic acid (synthetic), Extralink (synthetic), Gelin-S (porcine), Heparin and Water. • Biologically accurate - Rich in hyaluronic acid and denatured collagen, the Hystem-HP hydrogel closely mimics the complex three dimensional cellular environments found in life, providing an optimal environment for culturing your cells. | |
| Legal Information | Hystem is a trademark of Glycosan BioSystems, Inc. |
Properties
| storage temp. | −20°C |
Safety
| Hazard Codes | Xi |
| Risk Statements | 38-41-43 |
| Safety Statements | 26-36/37/39 |
